Non Invasive Cardiac Output Monitoring to Guide Goal Directed Fluid Therapy in High Risk Patients Undergoing Urgent Surgical Repair of Proximal Femoral Fractures
Launched by YORK TEACHING HOSPITALS NHS FOUNDATION TRUST · Mar 2, 2015
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
The management of fractured neck of femur in the elderly population is of clinical and political interest in the United Kingdom at present, with a current national audit in progress to look at anaesthetic management and clinical outcomes. It is estimated that the number of patients that sustain a hip fracture will reach 100,000 cases per annum by 2033 with a cost to the NHS of some £ 2.7 billion. Outcomes for this group remain poor with a mortality of 8% at 1 month, increasing to 20-33% at 1 year4. Complication rates for this group also remain significant with between 20 and 60% of patients...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients due to undergo urgent or emergency repair of a proximal femoral fracture who have a Nottingham hip fracture score (NHFS) ≥ 5 i.e. patients who are regarded as 'high risk'.
- Exclusion Criteria:
- • Age \< 50 years. Patients scoring 5 on the American Society of Anesthesiologists (ASA) physical status classification Multiple injuries requiring operative management
About York Teaching Hospitals Nhs Foundation Trust
York Teaching Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust focuses on facilitating innovative research initiatives that aim to enhance treatment options and improve health outcomes for patients. With a robust infrastructure supporting clinical trials, the Trust collaborates with a diverse range of stakeholders, including academic institutions and pharmaceutical companies, to drive evidence-based practices and ensure the highest standards of safety and efficacy in clinical research. Committed to fostering a culture of excellence, York Teaching Hospitals NHS Foundation Trust plays a pivotal role in the advancement of healthcare through research and innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
York, North Yorkshire, United Kingdom
Harrogate, Yorkshire, United Kingdom
Patients applied
Trial Officials
Simon Davies, MB FRCA MD
Principal Investigator
York Teaching Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials